Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET

Company Participants

David Connolly - Investor Relations and Corporate Communications

David Meeker - Chair, President and Chief Executive Officer

Jennifer Chien - Executive Vice President, Head of North America

Linda Shapiro - Chief Medical Officer

Hunter Smith - Chief Financial Officer

Yann Mazabraud - Executive Vice President, Head of International

Conference Call Participants

Derek Archila - Wells Fargo

Joseph Stringer - Needham & Company

Michael Higgins - Ladenburg Thalmann

Dae Gon Ha - Stifel

Jeff hung - Morgan Stanley

Corinne Jenkins - Goldman Sachs

Operator

Welcome to the Rhythm Pharmaceuticals First Quarter 2022 Earnings Conference Call. My name is Hilda and I'll be your operator today's call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session [Operator Instructions]. I would now turn the call over to, David Connolly, Investor Relations and Corporate Communications. You may begin.

David Connolly

Thank you, and good morning everybody. I'm Dave Connolly, Head of IR and Corporate Communications here at Rhythm Pharmaceuticals. For those of you participating via the conference call, the accompanying slides can be accessed and controlled by going to the Events section of the Investors page on our Web site at ir.rhythmtx.com. This morning, we issued a press release that provides our first quarter 2022 financial results and business update, which is available on our Web site. As listed on Slide 2, today here with me in Boston for the conference call are; David Meeker, Chair, President and Chief Executive Officer of Rhythm; Jennifer Chien, Executive Vice President, Head of North America; Linda Shapiro, our Chief Medical Officer; Hunter Smith, our Chief Financial Officer; Yann Mazabraud, Executive Vice President, Head of International is on the phone joining us from France.

With Slide 3, I'll remind you this call contains remarks concerning future expectations, plans and prospects, which constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in our most recent annual or quarterly report on file with the SEC. In addition, any forward-looking statements represent our views only as of today, and should not be relied upon as representing our views as of any subsequent dates. We specifically disclaim any obligation to update such statements.

With that, I'll turn the call over to David, who will being on Slide 5.